FarmaMondo reinforces its presence in the LATAM region by establishing a subsidiary in Montevideo, aiming to serve patients’ needs in this market and across all South America.

FarmaMondo reinforces its presence in the MEA region by establishing a subsidiary in Istanbul, aiming to serve more effectively the needs of the patients in this country.

FarmaMondo SA establishes its presence in Iberia by setting up a local subsidiary that is better placed to serve all Iberian HCPs and their patients’ needs and expectations.

FarmaMondo reinforces its presence in the MEA region by establishing a subsidiary in Dubai, aiming to serve patients’ needs in the region more effectively.

FarmaMondo started to reinforce its presence in the APAC region by establishing a subsidiaries in Hong Kong and Singapore, aiming to serve patients’ needs in the region more effectively. Since then we have become market authorisation holders in some APAC countries.

FarmaMondo establishes a subsidiary in Lithuania to enhance its infrastructure in the Baltic region and Ukraine.

FarmaMondo expands into the Nordic region by establishing its subsidiary in Denmark to cover the region’s five countries.

FarmaMondo reinforces its presence in Latin America by establishing a subsidiary in Argentina aiming to enhance its infrastructure in Argentina, Chile, Uruguay and Paraguay.

FarmaMondo expands into Russia and the CIS region, becoming the pioneer of unlicensed medicines and specialty commercialization services in Russia.

FarmaMondo SA and Farmacia Centrale are no longer a family-owned business. New leadership joins the company, led by a group of investors and experienced pharma entrepreneurs. A new era begins for FarmaMondo.

FarmaMondo partners for the first time with an innovator seeking to establish a managed access programme to serve unmet named patient needs.

70 years after its establishment, FarmaMondo has endured the test of time by always operating in a sustainable and responsible manner as any good Swiss business should. As medical needs and relevant regulations have evolved, so has FarmaMondo, becoming a solid pharmaceutical service business with a focus on supplying unlicensed medicines internationally

With the introduction of the internet, FarmaMondo gains wide recognition as a major brand providing access to Swiss medicines. Through a simple web page offering access to medicines, FarmaMondo becomes the supply partner of many healthcare providers in Europe and Asia.

The Swiss pharmaceutical market evolves during the 20^th century to become one of most advanced globally. This leads to cross-border demand for Swiss therapies from patients and doctors in neighbouring Italy. Farmacia Centrale develops a cross-border supply chain to serve unmet needs from Italy and other nearby countries.